Evofem Biosciences, Inc.
12400 High Bluff Drive, Suite 600
San Diego, CA 92130
May 17, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Irene Paik
Re: | Evofem Biosciences, Inc. |
Registration Statement onForm S-1 |
FileNo. 333-224958 |
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Evofem Biosciences, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests that the effective date of the above-captioned registration statement on FormS-1 (RegistrationNo. 333-224958) be accelerated so that the registration statement may become effective at 5:00 p.m., Eastern time, on Monday, May 21, 2018, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff. The Registrant hereby authorizes each of Adam C. Lenain, Melanie Ruthrauff Levy, Jacqulyn Lewis and Leanne Gould of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, to make such request on its behalf.
Please call Melanie Ruthrauff Levy(858-314-1873), Jacqulyn Lewis(858-314-1499) or Leanne Gould(858-314-2777) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, with any comments or questions regarding this matter.
Very truly yours, | ||
Evofem Biosciences, Inc. | ||
By: | /s/ Justin J. File | |
Name: Justin J. File | ||
Title: Chief Financial Officer |
cc: | Evofem Biosciences, Inc. |
Alexander Fitzpatrick |
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Adam C. Lenain
Melanie Ruthrauff Levy
Jacqulyn Lewis
Leanne Gould